MedTrace Logo

Breast Cancer Screening With Diffusion-weighted MRI in Women at High Risk for Breast Cancer

NCT03835897 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 890

Last updated 2020-11-23

No results posted yet for this study

Summary

A prospective observational multicenter study to compare the outcome of breast cancer surveillance using mammography, breast US, contrast-enhanced MRI, and diffusion-weighted MR imaging (DWI) as a screening tool, in the high-risk women for breast cancer.

* Primary objective: To compare the sensitivity of mammography, breast US, contrast-enhanced MRI, and DWI for the detection of breast cancer
* Secondary objective:

1. To compare the specificity of mammography, breast US, contrast-enhanced MRI, and DWI for the detection of breast cancer
2. To compare the cancer detection rate of mammography, breast US, contrast-enhanced MRI, and DWI
3. To compare the characteristics of detected cancers

Conditions

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Woo Kyung Moon, MD PhD · Professor

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-03
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03835897 on ClinicalTrials.gov